MAM
Madan Mohapatra to join OMS as Delhi branch head
MUMBAI: Madan Mohapatra, who recently quit Universal McCann, is all set to join OMS as head of the Delhi office.
Confirming the development to Indiantelevision.com, OMS president Sandeep Viz said that Mohapatra will be stepping into his new shoes towards the end of February.
As a direct result of Mohapatra’s appointment, OMS Delhi regional director Kajal Thakur has been transferred to OMS Bangalore, where she will be looking after new initiatives.
Mohapatra was, however unavailable for comment.
The news of Mohapatra’s new posting comes close on the heels of Starcom’s Gautam Rajgopal joining Optimum Media Solutions (OMS) as national buying head.
At Universal McCann, Mohapatra was business director handling the Nestle and L’oreal accounts. He joined Universal McCann in November last year from The Media Edge, where he was media director. Before TME, Mohapatra was with Starcom Worldwide for three years as associate media director – in charge of broadcast.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
